EPAD:GRF Informationists Administrative Supplement
EPAD:GRF 信息主义者行政补充
基本信息
- 批准号:9319505
- 负责人:
- 金额:$ 3.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAdministrative SupplementAdultAgingAlzheimer&aposs DiseaseArchitectureCandidate Disease GeneClinicalClinical DataCognitionCognitiveCohort StudiesDataData SetDetectionDevelopmentDiabetes MellitusDiagnosisDiseaseElderlyEpidemiologyExecutive DysfunctionFunding MechanismsGenesGeneticGenetic VariationGenotypeGoalsHealthHeightHeritabilityHypertensionInvestigationKnowledgeLate Onset Alzheimer DiseaseLeadMedical GeneticsMemoryMethodsNamesNucleotidesParentsParticipantPathway interactionsPatternPerformancePharmaceutical PreparationsPhenotypeProspective StudiesPsychometricsRandomizedReligion and SpiritualityResearchResearch PersonnelRiskRisk FactorsSeriesTimeVariantWashingtonWorkclinical epidemiologydisorder subtypedrug developmentexecutive functionexomeexome sequencingfamily structuregenetic analysisgenetic risk factorgenome sequencinggenome-wideimprovedneuropsychologicalprospectivewhole genome
项目摘要
DESCRIPTION (provided by applicant): Ten to 25% of people with late-onset Alzheimer's disease (AD) present with prominent executive deficits. Names such as frontal variant AD, executive prominent AD, and dysexecutive AD have been applied to this phenomenon. Little is known about traditional or genetic risk factors for dysexecutive AD. The overarching goal of this project is to further our understanding of the genetic architecture and clinical epidemiology of dysexecutive AD in the hopes of ultimately developing disease- modifying treatments. This project will leverage large-scale genome-wide genotype and sequence data and cognitive data collected on >17,000 participants across 19 collaborating studies. The investigators will use modern psychometric methods to co-calibrate cognitive data to develop scores on the same metric for memory and executive functioning. The investigators will use these scores to determine a continuous dysexecutive spectrum phenotype they have found to be highly heritable, with a pattern of heritability entirely distinct from that of AD. The investigators will
leverage genome-wide genotype data for Aim 1. Five of the collaborating studies are prospective cohort studies with extensive cognitive and clinical data from >10,000 participants. The investigators will leverage these data for Aim 2. Several funding mechanisms are producing whole genome and whole exome sequencing data for people with AD. The investigators will leverage these data for Aim 3. Taken together, these investigations promise to improve what is known about dysexecutive AD, a highly heritable and devastating AD subtype. This work may identify genetic loci associated with risk for dysexecutive AD, which in turn may lead to development of drugs that could dramatically improve the lives of people with this condition.
描述(由申请人提供):10%至25%的晚发性阿尔茨海默病(AD)患者存在明显的执行缺陷。诸如额叶变异型AD、执行突出型AD和执行障碍型AD等名称已被应用于这种现象。很少有人知道的传统或遗传的风险因素为dysexecutive AD。该项目的总体目标是进一步了解执行障碍性AD的遗传结构和临床流行病学,以期最终开发出改善疾病的治疗方法。该项目将利用19项合作研究中收集的超过17,000名参与者的大规模全基因组基因型和序列数据以及认知数据。研究人员将使用现代心理测量方法来共同校准认知数据,以制定记忆和执行功能相同指标的分数。研究人员将使用这些分数来确定他们发现的具有高度遗传性的连续执行障碍谱表型,其遗传性模式完全不同于AD。调查人员将
利用Aim 1的全基因组基因型数据。其中五项合作研究是前瞻性队列研究,具有来自> 10,000名参与者的广泛认知和临床数据。研究人员将利用这些数据实现目标2。一些资助机制正在为AD患者提供全基因组和全外显子组测序数据。研究人员将利用这些数据实现目标3。总的来说,这些研究有望改善对执行障碍AD的了解,这是一种高度遗传和破坏性的AD亚型。这项工作可能会确定与执行障碍AD风险相关的遗传位点,这反过来可能会导致药物的开发,从而大大改善患有这种疾病的人的生活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul K Crane其他文献
Paul K Crane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul K Crane', 18)}}的其他基金
Cognitively Defined Alzheimer's Subgroups: Natural history, neuropathology, and life course ramifications
认知定义的阿尔茨海默病亚组:自然史、神经病理学和生命历程的影响
- 批准号:
10672371 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Adult Changes in Thought (ACT) Research Program
成人思想变化 (ACT) 研究计划
- 批准号:
10404970 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Cognitively Defined Alzheimer's Subgroups: Natural history, neuropathology, and life course ramifications
认知定义的阿尔茨海默病亚组:自然史、神经病理学和生命历程的影响
- 批准号:
10404979 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Adult Changes in Thought (ACT) Research Program Core B: Clinical Core
成人思想转变 (ACT) 研究计划核心 B:临床核心
- 批准号:
10672348 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Adult Changes in Thought (ACT) Research Program Core B: Clinical Core
成人思想转变 (ACT) 研究计划核心 B:临床核心
- 批准号:
10404972 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Adult Changes in Thought (ACT) Research Program
成人思想变化 (ACT) 研究计划
- 批准号:
10672341 - 财政年份:2021
- 资助金额:
$ 3.3万 - 项目类别:
Genetic architecture of memory and executive functioning in Alzheimer's disease
阿尔茨海默病记忆和执行功能的遗传结构
- 批准号:
8630958 - 财政年份:2014
- 资助金额:
$ 3.3万 - 项目类别:
Genetic architecture of memory and executive functioning in Alzheimer's disease
阿尔茨海默病记忆和执行功能的遗传结构
- 批准号:
8919195 - 财政年份:2014
- 资助金额:
$ 3.3万 - 项目类别:
Genetic architecture of memory and executive functioning in Alzheimer's disease
阿尔茨海默病记忆和执行功能的遗传结构
- 批准号:
9297187 - 财政年份:2014
- 资助金额:
$ 3.3万 - 项目类别:
相似海外基金
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
- 批准号:
10833895 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
- 批准号:
10841820 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
- 批准号:
10850135 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
- 批准号:
10840220 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
- 批准号:
10844667 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
- 批准号:
10891050 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
- 批准号:
10711717 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
- 批准号:
10811292 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:
Administrative Supplement: Genome Resources for Model Amphibians
行政补充:模型两栖动物基因组资源
- 批准号:
10806365 - 财政年份:2023
- 资助金额:
$ 3.3万 - 项目类别:














{{item.name}}会员




